Phase I evaluation of seliciclib ( R-roscovitine), a novel oral cyclin-dependent kinase inhibitor, in patients with advanced malignancies

Autor: Le Tourneau, Christophe, Faivre, Sandrine, Laurence, Valérie, Delbaldo, Catherine, Vera, Karina, Girre, Veronique, Chiao, Judy, Armour, Sian, Frame, Sheelagh, Green, Simon R., Gianella-Borradori, Athos, Diéras, Veronique, Raymond, Eric
Zdroj: In European Journal of Cancer 2010 46(18):3243-3250
Databáze: ScienceDirect